Dr. Nathan Magarvey is the Founder and Chief Scientific Officer of Adapsyn Bioscience, and is responsible for all aspects of the company’s current collaboration with Pfizer. Additionally, he is an Associate Professor and Canada Research Chair in Natural Products and Chemical Biology in the Department of Biochemistry and Biomedical Sciences & Chemistry and Chemical Biology at McMaster University. He joined McMaster from Harvard Medical School and previously spent time in the pharmaceutical industry working for Wyeth Research, where he was directly involved in the discovery of new antibiotic and therapeutic microbial natural product small molecules. Dr. Magarvey’s research focuses on disrupting how the discovery of microbial metabolites is done- and in particular how to leverage the ability to connect Genomes to Natural Products, and his research has advanced the discovery of new microbial small molecules. His work leads to research intersecting the interfaces of medicine, biology, chemistry and computer science.
No general related URL provided
No related news for this person
Department of Biochemistry and Biomedical Sciences
McMaster Children's Hospital 1280 Main St W HSC - 4N59 Hamilton, Ontario, Canada L8S 4K1
Monday to Friday 8:30am to 4:30pm
Phone: 905-525-9140 ext. 22065 Fax: 905-522-9033
The Faculty of Health Sciences is committed to providing a website that is accessible to the widest possible audience. If there is an accessibility issue with this website, please contact us at email@example.com.